Wutah dodolan triwulanan Kineta Corp (KA)

KA (kinetabio.com) - tandha merek perusahaan

Kineta, Inc. is developing small-molecule agents to suppress tumor immunity amidst intense patent litigation. Quarter-over-quarter revenue growth helps identify hidden risks of declining income, while the 0.00 indicator determines the metric's magnitude. A liquidity shortage is forcing management to cut expenses. The asset's future depends on scientific breakthroughs rather than economic conditions.

KA (Kineta Inc) riwayat Tambahing pendapatan triwulanan saka 28.04.2023 nganti 28.09.2024

Rincian analitis perusahaan Kineta (KA)

- rega saham lan prakiraan rega para ahli:
Analisis kabeh metrik perusahaan:KA - Kineta Bio
Produk seri kinetabio.com

Kineta, Inc. (KA) faces a working capital deficit and a freeze on clinical trials, making the monitoring of liquidity inflows critical for assessing business viability. This quarterly revenue growth measures the percentage change in income relative to the previous period, allowing investors to distinguish genuine scaling from accounting adjustments and detect cash flow stagnation in a timely manner through the analysis of this chart.

Pesaing wigati

IBRX - Wutah pendapatan kuartal marang kuartal|IMCR (immunocore.com) - Wutah dodolan kuartal marang kuartal|Janux Corp (JANX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Arcus Bio (RCUS)|Wutah dodolan triwulanan ZYME|TNGX - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah dodolan triwulanan IOVA (Iovance)|Owah-owahan dodolan kuartal marang kuartal IMTX|Wutah pendapatan triwulanan XNCR (Xencor)|Tambahing pendapatan triwulanan CMPX|replimune.com - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Lyell Pharma|Innate Pharma S.A. (IPHA) - Wutah pendapatan kuartal marang kuartal|Pyxis Oncology Inc. - Tambahing pendapatan triwulanan|CGEN (Compugen Limited) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan IO Biotech Inc|Wutah pendapatan kuartal marang kuartal Sutro Biopharma (STRO)|INKT: Dinamika pendapatan kuartal marang kuartal|Werewolf Therapeutics, Inc. - Wutah dodolan triwulanan|Immix (IMMX) - Tingkat wutah pendapatan sajrone kuartal|ALX Oncology Holdings Inc. - Wutah pendapatan triwulanan|CUE - Wutah pendapatan triwulanan|PDSB: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan Liminatus Pharma (LIMN)|Wutah pendapatan triwulanan LVTX|Owah-owahan dodolan kuartal marang kuartal NXTC|Leap Therapeutics, Inc. - Wutah dodolan triwulanan|INTS: Wutah dodolan kuartal marang kuartal|Sensei Biotherapeutics Inc - Wutah pendapatan triwulanan|TOVX: Wutah pendapatan kuartal marang kuartal|gritstonebio.com (GRTS) - Wutah pendapatan kuartal marang kuartal|NexImmune Inc (NEXI) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Turnstone Biologics Corp.|Wutah dodolan kuartal marang kuartal VCNX (Vaccinex, Inc.)|Wutah dodolan triwulanan HARP (Harpoon Tx)